A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes.
N A Thornberry, H G Bull, J R Calaycay, K T Chapman, A D Howard, M J Kostura, D K Miller, S M Molineaux, J R Weidner, J Aunins
Index: Nature 356 , 768, (1992)
Full Text: HTML
Abstract
Interleukin-1 beta (IL-1 beta)-converting enzyme cleaves the IL-1 beta precursor to mature IL-1 beta, an important mediator of inflammation. The identification of the enzyme as a unique cysteine protease and the design of potent peptide aldehyde inhibitors are described. Purification and cloning of the complementary DNA indicates that IL-1 beta-converting enzyme is composed of two nonidentical subunits that are derived from a single proenzyme, possibly by autoproteolysis. Selective inhibition of the enzyme in human blood monocytes blocks production of mature IL-1 beta, indicating that it is a potential therapeutic target.
Related Compounds
Related Articles:
1997-06-01
[Hepatology 25 , 1516, (1997)]
Partial purification and characterization of two distinct types of caspases from human epidermis.
1998-09-01
[J. Invest. Dermatol. 111 , 367-372, (1998)]
Enzymatic activity of two caspases related to interleukin-1beta-converting enzyme.
1998-04-01
[Eur. J. Biochem. 253 , 76, (1998)]
1998-04-10
[Exp. Cell Res. 240 , 28, (1998)]